PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “Streptococcus salivarius”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 19 recordsLinked to original sources
PubMed1975

Streptococcus salivarius, Streptococcus sanguis and Streptococcus "mitis" as indicators of contamination of root canal cultures.

Small samples were taken from the first drop of saliva entering an operation field for root canal treatment isolated by rubber dam, which was intentionally leaky. The samples were primarly cultured in TAS- and BLH-medium and on MS-agar aerobically. The culture media were inoculated directly and via transport medium (VMG III). The cultures were analysed for Strep. salivarius, Strep. sanguis and/or Strep. "mitis" after subculture on MS-agar as soon as visible growth had appeared in the broth media and again after a further 2 days. The following observations were made: 1. Strep. salivarius was almost regularly found in either or both of TAS- and BLH-medium at primary culture of the samples contaminated with saliva. The result was the same whether these broth media were inoculated directly or via VMG III. 2. Strep. salivarius was always found in mixed cultures and was nearly always accompanied by Strep. sanguis and/or Strep. "mitis". 3. Strep. salivarius as well as Strep. sanguis survived two days after visible growth significantly more oftern in BLH-medium than in TAS-medium. The findings lend support to the hypothesis based on clinical studies that when present in root canal cultures Strep. salivarius is ascribable to contamination with saliva.

Adolescent↗
PubMed1977

[Synthesis of extracellular polysaccharides by various forms of Streptococcus salivarius].

Streptococcus salivarius synthesizes extracellular polysaccharides (EPS) from saccharose under aerobic and anaerobic conditions. Under aerobic conditions primarily soluble fructanes are formed. There are no differences between the EPS synthesized by r- and s-forms under aerobic conditions; anaerobically the s-forms produce more EPS and more fructane than the r-forms. As compared to streptococcus mutans, the streptococcus salivarius produces considerably more fructane and insoluble glucane under the conditions used.

Aerobiosis↗
PubMed2006

Megaplasmids encode differing combinations of lantibiotics in Streptococcus salivarius.

Streptococcus salivarius strains commonly produce bacteriocins as putative anti-competitor or signalling molecules. Here we report that bacteriocin production by the oral probiotic strain S. salivarius K12 is encoded by a large (ca. 190 kb) plasmid. Oral cavity transmission of the plasmid from strain K12 to a plasmid-negative variant of this bacterium was demonstrated in two subjects. Tests of additional S. salivarius strains showed large (up to ca. 220 kb) plasmids present in bacteriocin-producing isolates. Various combinations (up to 3 per plasmid) of loci encoding the known streptococcal lantibiotics salivaricin A, salivaricin B, streptin and SA-FF22 were localised to these plasmids. Since all bacteriocin-producing strains of S. salivarius tested to date appear to harbour plasmids, it appears that they may function as mobile repositories for bacteriocin loci, especially those of the lantibiotic class.

Bacterial Proteins↗
PubMed1994

Transport of mannose by an inducible phosphoenolpyruvate:fructose phosphotransferase system in Streptococcus salivarius.

Streptococcus salivarius transports mannose by a phosphoenolpyruvate:sugar phosphotransferase system (PTS) which consists of a membrane Enzyme II and two forms of Enzyme III (IIIMan) with molecular masses of 38.9 kDa (IIIManH) and 35.2 kDa (IIIManL) respectively. Using a pseudorevertant (strain 57P) isolated from a IIIManL-deficient spontaneous mutant unable to grow on mannose, we demonstrated that S. salivarius could also transport mannose by an inducible fructose PTS. This PTS phosphorylated fructose at the C-1 position with a high affinity (10 microM) and mannose at the C-6 position with a low affinity (200 microM). Derepression of this system in some IIIManL-deficient mutants would explain their ability to grow on mannose.

Binding, Competitive↗
PubMed1978

Tween 80 effect on glucosyltransferase synthesis by Streptococcus salivarius.

Streptococcus salivarius (ATCC 25975) produced very low or nondetectable amounts of the extracellular enzyme glucosyltransferase (GTase) when grown in a chemically defined medium. The addition of Tween 80 to this medium resulted in the production of markedly enhanced levels of the enzyme. Oleic acid, the methyl ester of oleic acid, and sucrose each could not substitute for Tween 80 in this regard. The surfactant had no direct activating effect on performed enzyme activity. Tween 80 also stimulated the production of GTase by concentrated cells suspended in defined medium during a time when no measurable growth occurred. Under these conditions, the stimulatory effect of Tween 80 was blocked by chloramphenicol. It was further found that the surfactant dramatically stimulated the differential rate of GTase synthesis. These and other data strongly suggest that Tween 80 stimulates the production of extracellular GTase by acting either directly or indirectly at the level of enzyme synthesis.

Chloramphenicol↗
PubMed1976

Antagonistic action of Streptococcus salivarius and Streptococcus faecalis to Mycobacterium tuberculosis.

Streptococcus salivarius and Streptococcus faecalis were found to inhibit the growth of Mycobacterium tuberculosis on Löwenstein-Jensen and Middlebrook 7H11 agars, but not on the latter medium when antibacterial drugs were added. S. faecalis was found to be more inhibitory than S. salivarius to 15 strains of M. tuberculosis. S. salivarius produced little or no inhibition of growth of Runyon group III organisms but was very antagonistic to Runyon group I mycobacteria.

Agar↗
PubMed1985

The cariogenicity of sucrose, glucose and maize starch in gnotobiotic rats mono-infected with strains of the bacteria Streptococcus mutans, Streptococcus salivarius and Streptococcus milleri.

Twenty-one-day-old weanling gnotobiotic WAG/RIJ rats were mono-infected with Streptococcus mutans NCTC 10832, Streptococcus salivarius JMB or Streptococcus milleri NCTC 11169, and maintained on a high carbohydrate diet containing sucrose, glucose or maize starch for 21-days. Fissure caries developed with all combinations of streptococcal strain and carbohydrate except maize starch/Streptococcus salivarius JMB. Caries incidence was highest with Streptococcus mutans NCTC 10832. For all species, the ranking of carbohydrates by cariogenic potential was sucrose greater than glucose greater than maize starch.

Animals↗
PubMed2001

Intra- and interspecies signaling between Streptococcus salivarius and Streptococcus pyogenes mediated by SalA and SalA1 lantibiotic peptides.

Streptococcus salivarius 20P3 produces a 22-amino-acid residue lantibiotic, designated salivaricin A (SalA), that inhibits the growth of a range of streptococci, including all strains of Streptococcus pyogenes. Lantibiotic production is associated with the sal genetic locus comprising salA, the lantibiotic structural gene; salBCTX genes encoding peptide modification and export machinery proteins; and salYKR genes encoding a putative immunity protein and two-component sensor-regulator system. Insertional inactivation of salB in S. salivarius 20P3 resulted in abrogation of SalA peptide production, of immunity to SalA, and of salA transcription. Addition of exogenous SalA peptide to salB mutant cultures induced dose-dependent expression of salA mRNA (0.2 kb), demonstrating that SalA production was normally autoregulated. Inactivation of salR encoding the response regulator of the SalKR two-component system led to reduced production of, and immunity to, SalA. The sal genetic locus was also present in S. pyogenes SF370 (M type 1), but because of a deletion across the salBCT genes, the corresponding lantibiotic peptide, designated SalA1, was not produced. However, in S. pyogenes T11 (M type 4) the sal locus gene complement was apparently complete, and active SalA1 peptide was synthesized. Exogenously added SalA1 peptide from S. pyogenes T11 induced salA1 transcription in S. pyogenes SF370 and in an isogenic S. pyogenes T11 salB mutant and salA transcription in S. salivarius 20P3 salB. Thus, SalA and SalA1 are examples of streptococcal lantibiotics whose production is autoregulated. These peptides act as intra- and interspecies signaling molecules, modulating lantibiotic production and possibly influencing streptococcal population ecology in the oral cavity.

Amino Acid Sequence↗
PubMed1978

Co-induction of beta-galactosidase and the lactose-P-enolpyruvate phosphotransferase system in Streptococcus salivarius and Streptococcus mutans.

The addition of lactose, galactose, or isopropyl-beta-D-thiogalactoside (IPTG) to glucose-grown cells of Streptococcus salivarius 25975 resulted in the co-induction of both the lactose-P-enolpyruvate phosphotransferase system (lactose-PTS) and beta-galactosidase, with the latter the predominant metabolic system. With various strains of Streptococcus mutans and Streptococcus sanguis 10556, on the other hand, the lactose-PTS was the major metabolic pathway with beta-galactosidase induced either to low or negligible levels. In all cases, induction of the lactose-PTS resulted in the concomitant induction of 6-P-beta-galactosidase. The induction by lactose of both the lactose-PTS and beta-galactosidase in all strains was repressed by glucose and other catabolites, notably, fructose. Induction of beta-galactosidase in S. salivarius 25975 by IPTG was, however, relatively resistant to glucose repression. Induction experiments with IPTG and lactose suggested that a cellular metabolite of lactose metabolism was a repressor of enzyme activity. Exogenous cAMP was shown to reverse the transient repression by glucose of beta-galactosidase induction in cells of S. salivarius 25975 receiving lactose, provided the cells were grown with small amounts of toluene to overcome the permeability barrier to this nucleotide, cAMP, was however, unable to overcome the permanent repression of beta-galactosidase activity to a significant extent under these conditions.

Cyclic AMP↗
PubMed1983

Control of sugar utilization in the oral bacteria Streptococcus salivarius and Streptococcus sanguis by the phosphoenolpyruvate: glucose phosphotransferase system.

Three different Strep. salivarius (G2, G5 and G29) and two Strep. sanguis (GS3 and GS12) mutants affected in the phosphoenolpyruvate: glucose phosphotransferase system were selected on agar plates containing lactose and 2-deoxyglucose. All 5 were defective in a membrane-bound component of the transport system and grew less rapidly than the parent strain in 5 mM glucose-containing medium. Mutants G2 and G29 grew poorly in the presence of 5 mM mannose. Growth on mixed substrates revealed that the mutants and wild-type parents behaved differently. Wild-type strains in medium containing glucose plus another sugar (lactose, galactose, melibiose, raffinose or trehalose for Strep. salivarius and lactose, galactose or trehalose for Strep. sanguis) always exhausted most of the glucose before utilizing the other sugar. The mutants used the second sugar concurrently or preferentially to glucose. In medium containing glucose plus fructose or mannose, the wild types consumed both sugars concurrently whereas the mutants utilized the second sugar before glucose. Mutants G2 and G5 were insensitive to repression by fructose and released glucose into the medium when grown in the presence of 0.4 per cent lactose. Mutant G5 also released galactose. Sugar release was not detected with the wild types. The Strep. salivarius mutants contained normal levels of glucokinase and beta-galactosidase but G5 was almost totally devoid of galactokinase activity after growth on lactose. On galactose, the activity was restored. It seems that the phosphoenolpyruvate: glucose phosphotransferase system is involved in the regulation of sugar utilization in these two streptococci.

Glucose↗
PubMed2005

Clinical characteristics and significance of Streptococcus salivarius bacteremia and Streptococcus bovis bacteremia: a prospective 16-year study.

The aim of this study was to determine the clinical significance of Streptococcus salivarius isolates recovered from blood cultures and compare them with isolates of Streptococcus bovis biotypes I and II. Seventeen of the 52 (32%) S. salivarius isolates recovered were considered clinically significant, compared with 62 of the 64 (97%) S. bovis isolates (p<0.0001). Bacteremia caused by S. salivarius occurred mostly in patients who showed relevant disruption of the mucous membranes and/or serious underlying diseases. Patients with S. salivarius bacteremia were younger than those with S. bovis bacteremia (57 vs. 67 years; p<0.01). Patients with S. salivarius bacteremia and patients with S. bovis II bacteremia had similar rates of endocarditis, colon tumors, and non-colon cancer. On the other hand, when compared with S. bovis I bacteremia, S. salivarius bacteremia was associated with lower rates of endocarditis (18% vs. 74%, respectively) (p<0.01) and colon tumors (0% vs. 57%, respectively) (p<0.005) and higher rates of non-colon cancer (53% vs. 9.5%, respectively) (p<0.01). Bacteremia caused by S. bovis II had a hepatobiliary origin in 50% of the patients, while, in contrast, that due to S. salivarius or S. bovis I was less frequently associated with a hepatobiliary origin (12% and 5%, respectively) (p<0.00001). The rate of penicillin resistance was 31% among S. salivarius isolates and 0% among S. bovis isolates (p<0.0001). In conclusion, the clinical characteristics of S. salivarius bacteremia and S. bovis II bacteremia are similar, and the isolation of S. salivarius in blood should not be systematically regarded as contamination.

Adult↗
PubMed2006

Safety assessment of the oral cavity probiotic Streptococcus salivarius K12.

Streptococcus salivarius is a prominent member of the oral microbiota and has excellent potential for use as a probiotic targeting the oral cavity. In this report we document safety data relating to S. salivarius K12, including assessment of its antibiogram, metabolic profiles, and virulence determinants, and we examine the microbial composition of saliva following the dosing of subjects with K12.

Anti-Bacterial Agents↗